Zu "319460-94-1" wurden 3 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
AG-13958
AG-13958

Artikelnummer: Cay41352-1

AG-13958 is an antagonist of VEGFR2 (Ki = 0.3 nM). It inhibits VEGF-induced proliferation of human umbilical vein endothelial cells (HUVECs, IC50 = 0.31 nM).Formal Name: N-[2-fluoro-5-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]amino]phenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide. CAS Number: 319460-94-1....
Schlagworte: N-[2-fluoro-5-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]amino]phenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide
Anwendung: VEGFR2 antagonist
CAS 319460-94-1
MW: 467.5 D
ab 88,00 €
Bewerten
AG-13958
AG-13958

Artikelnummer: TGM-T7493-100mg

Description: AG-13958 (AG-013958) (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular degeneration. Target: VEGFR. Smiles: Cc1cnn(C)c1C(=O)Nc1cc(Nc2ccc3c(\C=C\c4ccccn4)n[nH]c3c2)ccc1F. References: Barakat M R , Kaiser P . VEGF inhibitors for the treatment of neovascular...
Schlagworte: AG-013958
Anwendung: FLT/TYK receptor inhibitor
CAS 319460-94-1
MW: 467.5 D
ab 98,00 €
Bewerten
AG13958
AG13958

Artikelnummer: SYN-1004-M001

Soluble in DMSO. AG13958 is a VEGF inhibitor that was in clinical development for treatment of age-related macular degeneration (AMD). The drug displays low water solubility and so far in trials delivery has been difficult needing direct injection to be truly effective and it varied by the species used because of...
Schlagworte: AG-13958
Anwendung: FLT/TYK receptor inhibitor
CAS 319460-94-1
MW: 467,5 D
ab 385,00 €
Bewerten